Scholars Central

Mini reviewPublished 28 Apr 2023

Adult T cell Leukemia and Lymphoma Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant Risk Evaluation

Authors: Mayo Yoshimi

Department of Hematology and Immunology, Kagoshima University Hospital, Kagoshima, Japan

Transplant Reports : Open Access

Volume 8 · Issue 2 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Disease status at allogeneic hematopoietic cell transplantation (HCT) is an important pretransplant prognostic factor of HCT in adult T cell leukemia/ carcinoma (ATL); still, other prognostic factors, including comorbidities, weren't prophetic in small cohort analyses. Several scoring systems (HCT-specific comorbidity indicator (HCT- CI)/ modified European Group for Blood and Gist Transplantation threat score (mEBMT)) have been espoused to prognosticate HCT issues in other hematologic malice. We retrospectively estimated HCT- CI and mEBMT to prognosticate nonrelapse mortality (NRM) in 824 ATL cases registered in the Japan Society for Hematopoietic Cell Transplantation TRUMP database, from 2008 until 2013. A advanced HCT- CI was associated with lesser NRM when comparing HCT- CI 0 versus HCT- CI 1 to 3 and HCT- CI 0 versus HCT- CI ≥ 4. An advanced mEBMT score wasn't associated with advanced NRM when comparing mEBMT 0 to 3 with 4 to 6. Because ATL cases are aged and accordingly at threat of fresh complications, we developed an optimized prognostic indicator for ATL (ATL- HCT- PI) using known threat factors age, HCT- CI, and patron – philanthropist coitus combination. The ATL- HCT- PI scores effectively prognosticated the 2- time NRM (22.0, 27.7, and44.4, independently). Thus, the recently developed ATL- HCT- PI, in combination with other threat factors, is more useful for prognosticating NRM in HCT for ATL cases.

Subjects

Surgery

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalTransplant Reports : Open Access
  • SubjectSurgery
  • BylineArticles whose byline prints “Mayo Yoshimi”